(Q48179093)

9 February 2018

title

Intramuscular injection of 125I-botulinum neurotoxin-complex versus 125I-botulinum-free neurotoxin: time course of tissue distribution (English)

1 reference

https://api.crossref.org/works/10.1016/S0041-0101(03)00196-X

18 March 2024

author name string

Diane D-S Tang-Liu

1

1 reference

9 February 2018

Anton de Paiva

4

1 reference

9 February 2018

Colin Webber

7

1 reference

9 February 2018

K. Roger Aoki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529727

18 March 2024

J. Oliver Dolly

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529727

18 March 2024

Tara L. Houchen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529727

18 March 2024

Leslie F. Chasseaud

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529727

18 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14529727

18 March 2024

publication date

1 October 2003

1 reference

9 February 2018

number of pages

9

1 reference

full work available at URL

inferred from page(s)

https://api.elsevier.com/content/article/PII:S004101010300196X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0041-0101(03)00196-X

https://api.elsevier.com/content/article/PII:S004101010300196X?httpAccept=text/plain

18 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0041-0101(03)00196-X

18 March 2024

1 reference

9 February 2018

volume

42

1 reference

9 February 2018

issue

5

1 reference

9 February 2018

page(s)

461-469

1 reference

9 February 2018

Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2803%2900196-X

7 January 2021

Botulinum A toxin for the treatment of spasmodic torticollis: dysphagia and regional toxin spread

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2803%2900196-X

7 January 2021

Intramuscular Injection of Botulinum Toxin for the Treatment of Wrist and Finger Spasticity after a Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2803%2900196-X

7 January 2021

Productive and non-productive binding of botulinum neurotoxin A to motor nerve endings are distinguished by its heavy chain

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2803%2900196-X

7 January 2021

Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2803%2900196-X

7 January 2021

The effect of omitting botulinum toxin from the lower eyelid in blepharospasm treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2803%2900196-X

7 January 2021

Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2803%2900196-X

7 January 2021

Botulinum A toxin (Oculinum) in ophthalmology

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2803%2900196-X

7 January 2021

The median paralysis unit: A more pharmacologically relevant unit of biologic activity for botulinum toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2803%2900196-X

7 January 2021

Quantifying how location and dose of botulinum toxin injections affect muscle paralysis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2803%2900196-X

7 January 2021

Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2803%2900196-X

7 January 2021

Studies on the binding of botulinum toxin type A to the rat phrenic nerve-hemidiaphragm preparation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2803%2900196-X

7 January 2021

Radioiodination of Botulinum Neurotoxin Type A with Retention of Biological Activity and Its Binding to Brain Synaptosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2803%2900196-X

7 January 2021

Identifiers

1 reference

9 February 2018

1 reference

9 February 2018